Distinct association of factor V-Leiden and prothrombin G20210A mutations with deep venous thrombosis in Tunisia and Lebanon

American Journal of Hematology

Volumn 81, Issue 8, 2006, Pages 641-643

  Bouaziz Borgi, Lobna ^a   Almawi, Wassim Y ^b,c   Mtiraoui, Nabil ^a   Nsiri, Brahim ^d   Keleshian, Sose H ^c   Kreidy, Raghid ^e   Louzir, Bessem ^d   Hezard, Nathalie ^f   Mahjoub, Touhami ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b ARABIAN GULF UNIVERSITY   (Bahrain)

^c HAIGAZIAN UNIVERSITY   (Lebanon)

^d MILITARY HOSPITAL OF TUNIS   (Tunisia)

^e St Georges University Hospital   (Lebanon)

^f SERVICE DE DERMATOLOGIE   (France)

Author keywords

Factor V leiden; Genetics; Prothrombin G20210a; Venous thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADULT; AGED; ALLELE; ARTICLE; CAUCASIAN; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE MUTATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH RISK PATIENT; HUMAN; LEBANON; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TUNISIA;

ALLELES; FACTOR V; GENOTYPE; HUMANS; LEBANON; POINT MUTATION; PROTHROMBIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUNISIA; VENOUS THROMBOSIS;

EID: 33746025917     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20582     Document Type: Article

References (10)

1. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999;353:1167-1173.
2. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-67.
3. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-3703.
4. Almawi WY, Keleshian SH, Borgi L, Fawaz NA, Abboud N, Mtiraoui N, Mahjoub T. Varied prevalence of factor V G1691A (Leiden) and prothrombin G20210A single nucleotide polymorphisms among Arabs. J Thromb Thrombolys 2005;20:163-168.
5. Rees DC, Chapman NH, Webster MT, Guerreiro JF, Rochette J, Clegg JB. Born to clot: the European burden. Br J Haematol 1999;105:564-566.
6. Emmerich J, Rosendaal FR, Cattaneo M, Margaglione M, De Stefano V, Cumming T, Arruda V, Hillarp A, Reny JL. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism-pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism. Thromb Haemost 2001;86:809-816.
7. Almawi WY, Ameen G, Tamim H, Finan RR, Irani-Hakime N. Factor V, prothrombin G20210A, and methylenetetrahydrofolate reductase [MTHFR] C677T gene polymorphism in angiographically documented coronary artery disease. J Thromb Thrombolys 2004;17:199-205.
8. Tirado I, Mateo J, Soria JM, Oliver A, Borrell M, Coll I, Vallve C, Souto JC, Martinez-Sanchez E, Fontcuberta J. Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemostatic deficiencies. Haematologica 2001;86:1200-1208.
9. Dowling NF, Austin H, Dilley A, Whitsett C, Evatt BL, Hooper WC. The epidemiology of venous thromboembolism in Caucasians and African-Americans: the GATE Study. J Thromb Haemost 2003;1:80-87.
10. de Moerloose P, Reber G, Perrier A, Perneger T, Bounameaux H. Prevalence of factor V Leiden and prothrombin G20210A mutations in unselected patients with venous thromboembolism. Br J Haematol 2000;110:125-129.